Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device

NCT06772142 is registered in ClinicalTrials.gov with Nervonik as lead sponsor.

NCT NCT06772142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06772142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device
Lead sponsor
Nervonik
Phase
Phase 1
Overall status
Recruiting
Start date
November 27, 2024
Completion date
December 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral nerve disorder